Caption Guidance vs Tempus ECG-AF
AI Verdict
Choose Caption Guidance if…
Choose Caption Guidance if your clinical setting requires real-time, AI-powered assistance for acquiring high-quality cardiac ultrasound images, particularly for clinicians who may benefit from guided probe manipulation and automated quality assessment. This tool is ideal for improving the consistency and diagnostic quality of echocardiograms, enabling more efficient and accurate cardiac diagnostics at the point of care, especially in acute point-of-care settings like emergency departments or critical care units.
View Caption Guidance →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your objective is to proactively identify patients aged 65 or older at an increased risk of developing new-onset atrial fibrillation within the next year, utilizing existing 12-lead ECG data. This solution is best suited for integrating into cardiology or internal medicine workflows to enhance early detection and facilitate timely follow-up for at-risk elderly patients without a prior history of AF or other specified conditions.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Caption Guidance | Tempus ECG-AF |
|---|---|---|
| Pricing | Unknown | Contact vendor |
| Deployment | On-premise (integrated with ultrasound equipment) and cloud-based services. | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Caption GuidanceCaption Guidance offers real-time AI guidance for ultrasound probe manipulation and automated quality assessment, directly simplifying a complex diagnostic procedure for healthcare providers. Tempus ECG-AF, while valuable, is an analytical tool integrated into existing systems, providing results rather than interactive procedural guidance.
Clinical Value
Caption GuidanceCaption Guidance enhances access to and quality of diagnostic cardiac ultrasound images, a foundational step for accurate cardiac diagnosis, and includes automated ejection fraction calculation. Tempus ECG-AF provides risk stratification for AF, which is important for early intervention, but Caption Guidance's impact on the primary diagnostic acquisition process is arguably more fundamental to clinical care.
Pricing & Value
Tempus ECG-AFTempus ECG-AF has a clear path to financial viability for providers with established CMS reimbursement (CPT 0764T and CPT 0765T to APC 5734, Medicare rate of $128.90). Caption Guidance's pricing is enterprise-based and requires direct vendor contact, making its value proposition less transparent, although a direct-to-patient service has an introductory price of $299.
Enterprise Readiness
Caption GuidanceBoth tools are FDA-cleared, HIPAA compliant, and have BAAs, demonstrating strong foundational readiness. However, Caption Guidance's acquisition by GE HealthCare and its integration as a software accessory into specific GE ultrasound systems suggests a highly streamlined enterprise deployment and robust backing within a major medical device ecosystem.
Innovation
Caption GuidanceCaption Guidance is the first FDA-cleared AI-guided software that provides real-time guidance for ultrasound probe manipulation, a novel application of AI to directly assist and democratize a complex physical diagnostic procedure. While Tempus ECG-AF's predictive analytics for AF risk is innovative, the interactive guidance of Tool A represents a more disruptive innovation in clinical workflow.
Support & Docs
TieNeither the provided structured facts nor general web searches offer specific, comparable details regarding the depth or nature of support and documentation for either tool. Both companies are established in the healthcare AI space, suggesting they would offer standard enterprise-level support, but without explicit information, a distinction cannot be made.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Caption Guidance | Tempus ECG-AF |
|---|---|---|
| Tool Name | Caption Guidance | Tempus ECG-AF |
| Company | Caption Health (now part of GE HealthCare) | Tempus AI, Inc. |
| Primary Purpose | FDA-cleared AI-guided software that empowers healthcare providers to acquire diagnostic-quality cardiac ultrasound images with real-time guidance and automated quality assessment. | FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months. |
| Input Data Analyzed | Cardiac ultrasound images (real-time acquisition) | 12-lead ECG recordings |
| Target Patient Group | Not specified | Patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery |
| Key Output/Detection | Real-time AI guidance for ultrasound probe manipulation, automated quality assessment, auto-capture of diagnostic-quality ultrasound clips, automated ejection fraction calculation. | Identifies patients at increased risk of developing atrial fibrillation/flutter (AF) within 12 months. |
| Compatible Hardware/Systems | GE HealthCare Venue Family and Vscan Air SL ultrasound systems | FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems |
Videos
Demos, reviews, and walkthroughs featuring Caption Guidance and Tempus ECG-AF.